• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Prevalence characteristics of autoimmune thyroid disease in women aged 10-59 years in Qingdao City from 2022 to 2024].[2022年至2024年青岛市10至59岁女性自身免疫性甲状腺疾病的流行特征]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):507-513. doi: 10.19723/j.issn.1671-167X.2025.03.014.
2
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
3
[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].[1990年至2021年中国及全球年龄相关性听力损失的疾病负担及未来趋势预测]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):545-553. doi: 10.19723/j.issn.1671-167X.2025.03.019.
4
Changes in Epidemiological Characteristics of Varicella and Breakthrough Cases in Ningbo, China, From 2010 to 2023: Surveillance Study.2010年至2023年中国宁波水痘及突破性病例的流行病学特征变化:监测研究
JMIR Public Health Surveill. 2025 Jun 18;11:e71691. doi: 10.2196/71691.
5
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
6
Trends in the prevalence of autoimmune diseases during pregnancy in the UK, 2000-21: a retrospective cohort study.2000 - 2021年英国孕期自身免疫性疾病患病率趋势:一项回顾性队列研究。
Lancet Rheumatol. 2025 Jul;7(7):e495-e504. doi: 10.1016/S2665-9913(25)00039-6. Epub 2025 Jun 2.
7
Prevalence and determinants of eating disorder risk behaviours among adult women in Denmark: findings from nationwide cross-sectional health surveys between 2000 and 2023.丹麦成年女性饮食失调风险行为的患病率及影响因素:2000年至2023年全国横断面健康调查结果
J Eat Disord. 2025 Jun 16;13(1):112. doi: 10.1186/s40337-025-01318-7.
8
[Epidemiological characteristics of febrile seizure among children under 6 years old in Ningbo City from 2015 to 2021].2015年至2021年宁波市6岁以下儿童热性惊厥的流行病学特征
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):584-591. doi: 10.19723/j.issn.1671-167X.2025.03.024.
9
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
10
[Epidemiological investigation of asthenopia and dry eye among visual display terminal workers].视觉显示终端作业人员视疲劳与干眼的流行病学调查
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):554-561. doi: 10.19723/j.issn.1671-167X.2025.03.020.

本文引用的文献

1
Incidence and prevalence of autoimmune diseases in China: A systematic review and meta-analysis of epidemiological studies.中国自身免疫性疾病的发病率和患病率:一项流行病学研究的系统评价和荟萃分析
Glob Epidemiol. 2024 Aug 9;8:100158. doi: 10.1016/j.gloepi.2024.100158. eCollection 2024 Dec.
2
Graves disease: latest understanding of pathogenesis and treatment options.格雷夫斯病:发病机制和治疗选择的最新认识。
Nat Rev Endocrinol. 2024 Nov;20(11):647-660. doi: 10.1038/s41574-024-01016-5. Epub 2024 Jul 22.
3
Autoimmune Thyroid Diseases.自身免疫性甲状腺疾病
Semin Nucl Med. 2024 Mar;54(2):219-236. doi: 10.1053/j.semnuclmed.2023.11.002. Epub 2023 Dec 2.
4
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.自身免疫性疾病随时间推移以及按年龄、性别和社会经济状况的发生率、患病率和共病情况:英国 2200 万人的基于人群队列研究。
Lancet. 2023 Jun 3;401(10391):1878-1890. doi: 10.1016/S0140-6736(23)00457-9. Epub 2023 May 5.
5
Prevalence and risk factors of hypothyroidism after universal salt iodisation: a large cross-sectional study from 31 provinces of China.中国 31 个省份全民食盐碘化后甲状腺功能减退症的患病率及危险因素:一项大型横断面研究。
BMJ Open. 2023 Feb 28;13(2):e064613. doi: 10.1136/bmjopen-2022-064613.
6
Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: A systematic review and meta-analysis.全球成人桥本甲状腺炎的患病率和流行病学趋势:系统评价和荟萃分析。
Front Public Health. 2022 Oct 13;10:1020709. doi: 10.3389/fpubh.2022.1020709. eCollection 2022.
7
The Iodine Status and Prevalence of Thyroid Disorders Among Women of Childbearing Age in China: National Cross-sectional Study.中国育龄妇女碘营养状况及甲状腺疾病流行情况:全国横断面研究。
Endocr Pract. 2021 Oct;27(10):1028-1033. doi: 10.1016/j.eprac.2021.03.017. Epub 2021 Apr 8.
8
Autoimmune thyroid diseases after 25 years of universal salt iodisation: an epidemiological study of Chinese adults in areas with different water iodine levels.全民食盐加碘25年后的自身免疫性甲状腺疾病:不同水碘水平地区中国成年人的流行病学研究
Br J Nutr. 2020 Oct 28;124(8):853-864. doi: 10.1017/S0007114520001786. Epub 2020 May 21.
9
Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China.长期全民食盐碘化对甲状腺疾病的疗效和安全性:来自中国大陆 31 个省份的流行病学证据。
Thyroid. 2020 Apr;30(4):568-579. doi: 10.1089/thy.2019.0067. Epub 2020 Mar 24.
10
Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.桥本甲状腺炎:流行病学、发病机制、临床与治疗。
Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367. doi: 10.1016/j.beem.2019.101367. Epub 2019 Nov 26.

[2022年至2024年青岛市10至59岁女性自身免疫性甲状腺疾病的流行特征]

[Prevalence characteristics of autoimmune thyroid disease in women aged 10-59 years in Qingdao City from 2022 to 2024].

作者信息

Chen X, Yang J, Guo J, Li S, Liu Z, Zhu Y, Li F, Zhan S, Guo J

机构信息

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):507-513. doi: 10.19723/j.issn.1671-167X.2025.03.014.

DOI:10.19723/j.issn.1671-167X.2025.03.014
PMID:40509828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12171602/
Abstract

OBJECTIVE

To analyze the characteristics of Hashimoto thyroiditis (HT) and Graves disease (GD), two autoimmune thyroid diseases aged 10-59 in Qingdao City from 2022 to 2024, and to provide scientific basis for making targeted prevention and treatment measures.

METHODS

A cross-sectional study design was adopted, based on the data of the Regional Health Information Platform in Qingdao, the confirmed cases of HT and GD from 2022 to 2024 were included, and combined with the data of the seventh population census, the three-year and annual prevalence rates of HT and GD were calculated, and the time trend of annual prevalence was analyzed by Cochran-Armitage trend test. The distribution characte-ristics of HT and GD prevalence in different age groups and regions were analyzed, and Chi-square test was used to compare the differences between the groups.

RESULTS

The total number of HT patients among women aged 10-59 in Qingdao City from 2022 to 2024 was 40 362. The proportion of HT patients in 30- 34 years old was the highest (19.83%). The proportion of HT patients in Huangdao District was the highest (17.72%). The three-year prevalence of HT was 1 206.53/100 000. In 2022-2024, the annual prevalence of HT increased significantly ( < 0.001), from 385.32/100 000 in 2022 to 1 206.32/ 100 000 in 2024. The three-year prevalence of HT was significantly different in age distribution ( < 0.001). The three-year prevalence of HT in 25-29 years (2 354.44/100 000) and 35-39 years (2 022.20/100 000) was higher than that in other age groups, showing a bimodal distribution. There were significant differences in the three-year prevalence of HT in different regions ( < 0.001), among which the three-year prevalence of HT in Shinan District was the highest (2 392.90/100 000), followed by Licang District (1 492.41/100 000), and Laixi City was the lowest (659.940/100 000). The total number of GD patients was 2 095, among which the proportion of GD patients in the 35-39 age group was the highest (15.42%), and the proportion of GD patients from Jimo District was the highest (12.27%). From 2022 to 2024, the three-year prevalence rate of GD was 62.63/100 000, and the annual prevalence rate of GD showed an increasing trend ( < 0.001), from 20.33/100 000 in 2022 to 62.63/100 000 in 2024. There were significant differences in the prevalence of GD by age ( < 0.001). The three-year prevalence of GD reached the highest value in the 25-29 age group (98.90/100 000), followed by the 35-39 age group (85.21/100 000), and the lowest in the 10-14 age group (14.43/100 000). In the regional distribution, there were significant differences in the 3-year prevalence of GD ( < 0.001). Laoshan District had the highest three-year prevalence of GD (107.58/100 000), followed by Shinan District (97.83/100 000) and Huangdao District (28.92/100 000).

CONCLUSION

The three-year pre-valence of HT and GD in females aged 10-59 years in Qingdao City from 2022 to 2024 is low, but the annual prevalence is on the rise, and the three-year prevalence of HT and GD in females aged 25-39 years is higher than that in other age groups, so it is necessary to strengthen the screening and monitoring of this population.

摘要

目的

分析2022年至2024年青岛市10至59岁的两种自身免疫性甲状腺疾病——桥本甲状腺炎(HT)和格雷夫斯病(GD)的特征,为制定针对性的防治措施提供科学依据。

方法

采用横断面研究设计,基于青岛市区域卫生信息平台的数据,纳入2022年至2024年确诊的HT和GD病例,并结合第七次人口普查数据,计算HT和GD的三年患病率和年患病率,采用 Cochr an-Armitage趋势检验分析年患病率的时间趋势。分析HT和GD患病率在不同年龄组和地区的分布特征,采用卡方检验比较组间差异。

结果

2022年至2024年青岛市10至59岁女性中HT患者总数为40362例。30至34岁HT患者所占比例最高(19.83%)。黄岛区HT患者所占比例最高(17.72%)。HT的三年患病率为1206.53/10万。2022年至2024年,HT的年患病率显著上升(<0.001),从2022年的385.32/10万升至2024年的1206.32/10万。HT的三年患病率在年龄分布上有显著差异(<0.001)。25至29岁(2354.44/10万)和35至39岁(2022.20/10万)HT的三年患病率高于其他年龄组,呈双峰分布。HT的三年患病率在不同地区有显著差异(<0.001),其中市南区HT的三年患病率最高(2392.90/10万),其次是李沧区(1492.41/10万),莱西市最低(659.940/10万)。GD患者总数为2095例,其中35至39岁GD患者所占比例最高(15.42%),即墨区GD患者所占比例最高(12.27%)。2022年至